Business
Endonovo Therapeutics Appoints Dr. Roc Alan McCarthy as a Scientific Advisory Board Member
Endonovo Therapeutics Appoints Dr. Roc Alan McCarthy as a Scientific Advisory Board Member.
About this update from Endonovo Therapeutics, Inc.
[{"type":"text","content":"\nLos Angeles, CA , May 09, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced, that Roc Alan McCarthy, D.O. will be joining the company as a Scientific Advisory Board Member. Dr. McCarthy will help Endonovo continue to advance their clinical pipeline forward and contribute to the strategic and clinical development oversight of the company.\n Dr. McCarthy is a Urologist in North Carolina, currently serving as the robotic surgeon and Chairmen of the robotics committee at New Hanover Regional Medical Center. Dr. McCarthy received his Bachelor of Science from Coastal Carolina University in 1998, Master’s Degree of Science in Renal Physiology at University of Georgia in 2000 and Doctor of Osteopathic Medicine at Pikeville College School of Osteopathetic Medicine in 2004. Dr. McCarthy has performed over 800 surgical cases for six straight years with 150-200 robotic cases per year and over 1,200 robotic surgeries since completing his residency in 2005 at the POH Medical Center. “I am honored to serve on the Scientific Advisory Board of Endonovo Therapeutics,” said Dr. McCarthy. “I look forward to helping the company as it works to advance products in the industry and improve the lives of post-operative patients.” Alan Collier, Endonovo’s Chief Executive Officer, stated, \" “We are confident Roc’s insights and experience will be a huge asset to Endonovo as we continue to develop our clinical programs and studies. Roc’s awards, activities and professional affiliations will prove invaluable as we continue to advance our leading product toward a national rollout and ultimately improve the lives of patients globally. I believe this is an important moment in our growth and I look forward to working with Dr. McCarthy to help further our goal of bringing differentiated treatments to patients and eliminating drugs to post-op patients.” About Endonovo Therapeutics Endonovo Therapeutics, Inc. is a commercial-stage developer of non-invasive wearable Electroceuticals™ therapeutic devices. The Company's current portfolio of commercial and clinical-stage wearable Electroceuticals™ therapeutic devices addresses wound healing, pain, post-surgical pain and edema, cardiovascular disease, chronic kidney disease, and Central Nervous System (CNS) D...